{"slideshow_credits": null, "snippet": "India\u2019s mass production of generic versions of drugs patented elsewhere helps poor people with treatment that would otherwise be too costly, but drug companies say the knockoffs stifle innovation.", "abstract": "India\u2019s mass production of generic versions of drugs protected by global patents helps poor people with treatments that would otherwise be too costly, but drug companies say the knockoffs stifle innovation; case involving Novartis's cancer drug Gleevec before the Indian Supreme court represents a high-stakes showdown between defenders of intellectual property rights and Indian drug companies and international aid groups that warn that ruling in favor of Novartis could have lasting effects on the global supply chain of inexpensive drugs.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Vikas", "role": "reported", "lastname": "BAJAJ", "rank": 1, "organization": ""}, {"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 2, "organization": ""}], "original": "By VIKAS BAJAJ and ANDREW POLLACK", "contributor": "Vikas Bajaj reported from Mumbai, India, and Andrew Pollack from Los Angeles."}, "web_url": "http://www.nytimes.com/2012/03/07/business/global/indias-supreme-court-to-hear-long-simmering-dispute-on-drug-patents.html", "lead_paragraph": "India\u2019s mass production of generic versions of drugs patented elsewhere helps poor people with treatment that would otherwise be too costly, but drug companies say the knockoffs stifle innovation.", "headline": {"main": "India\u2019s Supreme Court to Hear Dispute on Drug Patents", "print_headline": "Patent v. Patient"}, "_id": "53f4505238f0d857ea2d0e8d", "word_count": "1455", "multimedia": [{"height": 350, "url": "images/2012/03/07/business/global/07generics-span/07generics-span-articleLarge.jpg", "legacy": {"xlarge": "images/2012/03/07/business/global/07generics-span/07generics-span-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "350"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2012/03/07/business/global/07generics-span/07generics-span-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2012/03/07/business/global/07generics-span/07generics-span-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-03-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "India", "name": "glocations", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Inventions and Patents", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Suits and Litigation", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "International Trade and World Market", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Novartis AG", "name": "organizations", "is_major": "Y", "rank": "7"}], "blog": [], "subsection_name": "Global Business", "type_of_material": "News"}